Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.

Barone, G; Bunke, C M; Choc, M G; Hricik, D E; Jin, J H; Klein, J B; Marsh, C L; Min, D I; Pescovitz, M D; Pollak, R; Pruett, T L; Stinson, J B; Thompson, J S; Vasquez, E; Waid, T; Wombolt, D G; Wong, R L

Barone, G; Bunke, C M; Choc, M G; Hricik, D E; Jin, J H; Klein, J B; Marsh, C L; Min, D I; Pescovitz, M D; Pollak, R; Pruett, T L; Stinson, J B; Thompson, J S; Vasquez, E; Waid, T; Wombolt, D G; Wong, R L.

Affiliation

Barone G; Department of Vascular and Transplant Surgery, University of Arkansas, USA.

Transplant Proc ; 28(4): 2183-6, 1996 Aug.

Article in En | MEDLINE | ID: mdl-8769194

Subject(s)

Cyclosporine/adverse effects; Immunosuppressive Agents/adverse effects; Kidney Transplantation/immunology; Administration, Oral; Adult; Aged; Blood Pressure; Creatinine/blood; Cyclosporine/administration & dosage; Double-Blind Method; Female; Graft Rejection/epidemiology; Humans; Immunosuppressive Agents/administration & dosage; Kidney Transplantation/physiology; Male; Middle Aged; Transplantation, Homologous

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Cyclosporine / Immunosuppressive Agents Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 1996 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links